Flagship explainer
What drives CATALYST PHARMACEUTICALS, INC.’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $214M | FY2025 |
| |
| Income before tax | $284M | FY2025 |
|
| Operating income | $258M | FY2025 |
|
| $589M | FY2025 |
| |
| Ending assets | $1.1B | FY2025 |
|
| Beginning assets | $851M | FY2024 |
|
| $954M | FY2025 |
| |
| $728M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001193125-26-071525
- SEC filingFiling detailsAccession 0001193125-26-197490